Yu Liu
机构:Nanjing University of Chinese Medicine, Anhui University of Traditional Chinese Medicine · ORCID:0000-0002-8558-7300
发表论文 28 篇 · 总被引 495 次 · h-index 9
代表论文
- Biotin-Targeted Au(I) Radiosensitizer for Cancer Synergistic Therapy by Intervening with Redox Homeostasis and Inducing Ferroptosis (2022 · Journal of Medicinal Chemistry · 被引 44)
- Inhibition of Nickel Nanoparticles-Induced Toxicity by Epigallocatechin-3-Gallate in JB6 Cells May Be through Down-Regulation of the MAPK Signaling Pathways (2016 · PLoS ONE · 被引 39)
- MicroRNA-375 represses tumor angiogenesis and reverses resistance to sorafenib in hepatocarcinoma (2020 · Cancer Gene Therapy · 被引 38)
- Curcumin, as a pleiotropic agent, improves doxorubicin-induced nephrotic syndrome in rats (2019 · Journal of Ethnopharmacology · 被引 38)
- Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site (2018 · European Journal of Medicinal Chemistry · 被引 32)
- Zinc regulates a specific subpopulation of VEGFA + microglia to improve the hypoxic microenvironment for functional recovery after spinal cord injury (2023 · International Immunopharmacology · 被引 26)